Literature DB >> 18853119

Effect of Jinguo Weikang Capsule on proto-oncogene expression of gastric mucosa in rats with gastric precancerous lesions.

Shu-wen Shen1, Ya Yuwen, Zhen-lu Zhang, Sheng Dong, Jun-tian Liu, Xiao-mei Wang.   

Abstract

OBJECTIVE: To study the effect of Jinguo Weikang Capsule [see text] on the gene expression of H-ras, epidermal growth factor receptor (EGFR), P53 and C-myc of the gastric mucosa in rats with gastric precancerous lesions, and to investigate the action mechanism of JWC on gastric precancerous lesions.
METHODS: A rat model with paratypical proliferation of the gastric epithelium mucosa was established by using 60Co irradiation. Rats were divided into the normal group, model group, high-, medium-, low-dose JWC treatment groups, and the vitacoenzyme control group, and were treated for 30 days. The expression of H-ras, EGFR, P53 and C-myc genes of the gastric mucosa was detected by using immunohistochemical methods.
RESULTS: The expression and over-expression rates of H-ras, EGFR, P53 and C-myc gene in the high-and medium-dose JWC treatment groups were significantly lower (P<0.05) as compared with those of the model group.
CONCLUSION: JWC can inhibit the expression of the H-ras, EGFR, P53 and C-myc genes expression of the gastric mucosa in rats, which may be one of mechanisms involved in suppressing or reversing gastric carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18853119     DOI: 10.1007/s11655-008-0212-3

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  4 in total

1.  p53 alteration in gastric precancerous lesions.

Authors:  Y H Shiao; M Rugge; P Correa; H P Lehmann; W D Scheer
Journal:  Am J Pathol       Date:  1994-03       Impact factor: 4.307

2.  [Clinical and experimental study on gastrosia convalescens in treating chronic atrophic gastritis].

Authors:  C Y Li; X Y Shi; S J Zhou
Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi       Date:  1995-01

3.  Establishment and characterization of a human gastric scirrhous carcinoma cell line in serum-free chemically defined medium.

Authors:  K Yanagihara; N Kamada; M Tsumuraya; F Amano
Journal:  Int J Cancer       Date:  1993-05-08       Impact factor: 7.396

4.  Proliferating cell nuclear antigen labeling index of preoperative biopsy specimens in gastric carcinoma with special reference to prognosis.

Authors:  K Maeda; Y S Chung; N Onoda; Y Kato; A Nitta; Y Arimoto; N Yamada; Y Kondo; M Sowa
Journal:  Cancer       Date:  1994-02-01       Impact factor: 6.860

  4 in total
  5 in total

1.  MOXIBUSTION ALLEVIATES GASTRIC PRECANCEROUS LESIONS IN RATS BY PROMOTING CELL APOPTOSIS AND INHIBITING PROLIFERATION-RELATED ONCOGENES.

Authors:  Li Peng; Yu-Feng Xie; Chen-Guang Wang; Huan-Gan Wu; Mi Liu; Ya-Dong Wang; Fu-Qiang Ma; Xiao-Rong Chang; Zong-Bao Yang
Journal:  Afr J Tradit Complement Altern Med       Date:  2017-01-13

2.  Exploring the potential pharmacodynamic material basis and pharmacologic mechanism of the Fufang-Xialian-Capsule in chronic atrophic gastritis by network pharmacology approach based on the components absorbed into the blood.

Authors:  Shizhe Li; Tengfei Xu; Shu Liu; Zhiqiang Liu; Zifeng Pi; Fenrui Song; Yongri Jin
Journal:  R Soc Open Sci       Date:  2018-06-13       Impact factor: 2.963

3.  Effects of Shen Cao Granules on Chemotherapy-Induced Thrombocytopenia in Gastrointestinal Cancer Patients: A Randomized Controlled Trial.

Authors:  Chunfeng Yu; Wei Liu; Yuejun Mu; Aihua Hou; Yin Li
Journal:  Integr Cancer Ther       Date:  2019 Jan-Dec       Impact factor: 3.279

4.  Genome-wide transcriptional analysis of Aristolochia manshuriensis induced gastric carcinoma.

Authors:  Lianmei Wang; Chunying Li; Jingzhuo Tian; Jing Liu; Yong Zhao; Yan Yi; Yushi Zhang; Jiayin Han; Chen Pan; Suyan Liu; Nuo Deng; Zhong Xian; Guiqin Li; Xin Zhang; Aihua Liang
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.503

5.  Epigallocatechin Gallate Protects against MNNG-Induced Precancerous Lesions of Gastric Carcinoma in Rats via PI3K/Akt/mTOR Pathway.

Authors:  Feiye Zhu; Yanli Xu; Jieli Pan; Meiya Li; Fangming Chen; Guanqun Xie
Journal:  Evid Based Complement Alternat Med       Date:  2021-02-05       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.